NVS - Novartis reports Phase 3 results for IgA nephropathy treatment
2024-05-28 09:44:46 ET
More on Novartis
- Novartis: Buy This Blue-Chip Dividend Stock On Sale Now
- Novartis AG (NVS) Q1 2024 Earnings Call Transcript
- Novartis: Strong Start To The Year With Beat-And-Raise First Quarter Results
- ADHD diagnoses increasing, becoming an 'expanding public health concern': CDC
- MorphoSys gains after Novartis discloses all tender offer conditions were met